Literature DB >> 4537232

Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.

D A Evans, M F Bullen, J Houston, C A Hopkins, J M Vetters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4537232      PMCID: PMC1469207          DOI: 10.1136/jmg.9.1.53

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  9 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  Autoimmune antibodies in mongol families.

Authors:  P J Wren; D A Evans; J M Vetters; A Chew
Journal:  Lancet       Date:  1967-07-22       Impact factor: 79.321

3.  Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.

Authors:  H M Perry; E M Tan; S Carmody; A Sakamoto
Journal:  J Lab Clin Med       Date:  1970-07

Review 4.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616

5.  Induction by isoniazid and hydrallazine of antinuclear factors in mice.

Authors:  A Cannat; M Seligmann
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

6.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

7.  Genetic variations in the acetylation of isoniazid and other drugs.

Authors:  D A Evans
Journal:  Ann N Y Acad Sci       Date:  1968-07-31       Impact factor: 5.691

8.  Possible induction of antinuclear antibodies by isoniazid.

Authors:  A Cannat; M Seligmann
Journal:  Lancet       Date:  1966-01-22       Impact factor: 79.321

9.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
  9 in total
  7 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

2.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

3.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

Review 4.  Drug-induced lupus erythematosus: an update on drugs and mechanisms.

Authors:  Ye He; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-09       Impact factor: 5.006

Review 5.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

Review 6.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  The association of the slow acetylator phenotype with bladder cancer.

Authors:  D A Evans; L C Eze; E J Whibley
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.